129 related articles for article (PubMed ID: 17163401)
1. Gastric and intestinal phenotypic correlation between exocrine and endocrine components in human stomach tumors.
Takenaka Y; Tsukamoto T; Mizoshita T; Ogasawara N; Hirano N; Otsuka T; Ban H; Nakamura T; Yamamura Y; Kaminishi M; Tatematsu M
Histol Histopathol; 2007 Mar; 22(3):273-84. PubMed ID: 17163401
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemically detectable Cdx2 is present in intestinal phenotypic elements in early gastric cancers of both differentiated and undifferentiated types, with no correlation to non-neoplastic surrounding mucosa.
Mizoshita T; Tsukamoto T; Inada K; Ogasawara N; Hirata A; Kato S; Joh T; Itoh M; Yamamura Y; Tatematsu M
Pathol Int; 2004 Jun; 54(6):392-400. PubMed ID: 15144397
[TBL] [Abstract][Full Text] [Related]
3. Exocrine and endocrine modulation in common gastric carcinoma.
Canzonieri V; Colarossi C; Del Col L; Perin T; Talamini R; Sigon R; Cannizzaro R; Aiello E; Buonadonna A; Italia F; Massi D; Carbone A; Memeo L
Am J Clin Pathol; 2012 May; 137(5):712-21. PubMed ID: 22523208
[TBL] [Abstract][Full Text] [Related]
4. Coexistence of gastric- and intestinal-type endocrine cells in gastric and intestinal mixed intestinal metaplasia of the human stomach.
Otsuka T; Tsukamoto T; Mizoshita T; Inada K; Takenaka Y; Kato S; Yamamura Y; Miki K; Tatematsu M
Pathol Int; 2005 Apr; 55(4):170-9. PubMed ID: 15826243
[TBL] [Abstract][Full Text] [Related]
5. Down regulation of gastric and intestinal phenotypic expression in Epstein-Barr virus-associated stomach cancers.
Hirano N; Tsukamoto T; Mizoshita T; Koriyama C; Akiba S; Campos F; Carrasquilla G; Carrascal E; Cao X; Toyoda T; Ban H; Miki K; Tatematsu M
Histol Histopathol; 2007 Jun; 22(6):641-9. PubMed ID: 17357094
[TBL] [Abstract][Full Text] [Related]
6. The incidence of chromogranin A defined endocrine cells decreases with tumour progression in gastric adenocarcinoma.
Ikeda Y; Mori M; Haraguchi Y; Sasaki O; Sugimachi K
Surg Oncol; 1995; 4(5):255-60. PubMed ID: 8850027
[TBL] [Abstract][Full Text] [Related]
7. [Comparative study of endocrine differentiation in early and advanced stomach carcinoma].
Melissari M; Giordano G; Saragoni L; Bordi C
Pathologica; 1997 Apr; 89(2):133-7. PubMed ID: 9411359
[TBL] [Abstract][Full Text] [Related]
8. Expression of neural cell adhesion molecule in normal gastric mucosa and in gastric carcinoid tumors.
Sakamoto J; Watanabe T; Kito T; Yamamura Y; Kiriyama K; Kannagi R; Ueda R; Takagi H; Takahashi T
Eur Surg Res; 1994; 26(4):230-9. PubMed ID: 7957459
[TBL] [Abstract][Full Text] [Related]
9. Tubular adenoma and intramucosal intestinal-type adenocarcinoma of the stomach: what are the pathobiological differences?
Kase S; Osaki M; Honjo S; Adachi H; Ito H
Gastric Cancer; 2003; 6(2):71-9. PubMed ID: 12861397
[TBL] [Abstract][Full Text] [Related]
10. Mixed gastric carcinoma with intestinal and cribriform patterns: a distinctive pathologic appearance associated with poor prognosis in advanced stages and a potential mimicker of metastatic breast carcinoma.
Lino-Silva LS; Salcedo Hernández RA; Molina-Frías E
Int J Surg Pathol; 2013 Feb; 21(1):6-14. PubMed ID: 22744963
[TBL] [Abstract][Full Text] [Related]
11. Gastric-and-intestinal mixed endocrine cell phenotypic expression of carcinoid tumors in the rectum.
Hirata Y; Mizoshita T; Mizushima T; Shimura T; Mori Y; Kubota E; Wada T; Ogasawara N; Tanida S; Kataoka H; Sasaki M; Kamiya T; Tsukamoto T; Tatematsu M; Joh T
Oncol Rep; 2009 Jan; 21(1):107-12. PubMed ID: 19082450
[TBL] [Abstract][Full Text] [Related]
12. [Primary gastric endocrine tumors].
Liu SM; Liu XY; Zou SM; Wei GL; Sun YT
Zhonghua Bing Li Xue Za Zhi; 2003 Feb; 32(1):38-42. PubMed ID: 12760802
[TBL] [Abstract][Full Text] [Related]
13. Loss of phenotypic expression is related to tumour progression in early gastric differentiated adenocarcinoma.
Nakamura T; Yao T; Kabashima A; Nishiyama K; Maehara Y; Tsuneyoshi M
Histopathology; 2005 Oct; 47(4):357-67. PubMed ID: 16178890
[TBL] [Abstract][Full Text] [Related]
14. Colonic and small-intestinal phenotypes in gastric cancers: relationships with clinicopathological findings.
Mizoshita T; Tsukamoto T; Tanaka H; Takenaka Y; Kato S; Cao X; Joh T; Tatematsu M
Pathol Int; 2005 Oct; 55(10):611-8. PubMed ID: 16185290
[TBL] [Abstract][Full Text] [Related]
15. Expression of Cdx2 and the phenotype of advanced gastric cancers: relationship with prognosis.
Mizoshita T; Tsukamoto T; Nakanishi H; Inada K; Ogasawara N; Joh T; Itoh M; Yamamura Y; Tatematsu M
J Cancer Res Clin Oncol; 2003 Dec; 129(12):727-34. PubMed ID: 14557879
[TBL] [Abstract][Full Text] [Related]
16. [Clinicopathologic and immunohistochemical study on early gastric signet-ring cell carcinoma].
Xiong ZF; Xiao H; Tan YS
Zhonghua Bing Li Xue Za Zhi; 2010 Jul; 39(7):442-6. PubMed ID: 21055171
[TBL] [Abstract][Full Text] [Related]
17. Expression of cyclin-dependent kinase inhibitor p21WAF1/CIP1 in non-neoplastic mucosa and neoplasia of the stomach: relationship with p53 status and proliferative activity.
Yasui W; Akama Y; Kuniyasu H; Yokozaki H; Semba S; Shimamoto F; Tahara E
J Pathol; 1996 Oct; 180(2):122-8. PubMed ID: 8976868
[TBL] [Abstract][Full Text] [Related]
18. Cdx2 transcription factor regulates claudin-3 and claudin-4 expression during intestinal differentiation of gastric carcinoma.
Satake S; Semba S; Matsuda Y; Usami Y; Chiba H; Sawada N; Kasuga M; Yokozaki H
Pathol Int; 2008 Mar; 58(3):156-63. PubMed ID: 18251778
[TBL] [Abstract][Full Text] [Related]
19. High expression of L-type amino-acid transporter 1 (LAT1) in gastric carcinomas: comparison with non-cancerous lesions.
Ichinoe M; Mikami T; Yoshida T; Igawa I; Tsuruta T; Nakada N; Anzai N; Suzuki Y; Endou H; Okayasu I
Pathol Int; 2011 May; 61(5):281-9. PubMed ID: 21501294
[TBL] [Abstract][Full Text] [Related]
20. Intestinal phenotypic expression of gastric depressed adenomas and the surrounding mucosa.
Oya M; Yao T; Nakamura T; Nakanishi K; Tsuneyoshi M
Gastric Cancer; 2003; 6(3):179-84. PubMed ID: 14520532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
